PR Newswire
NEW DELHI, March 25, 2026
NEW DELHI, March 25, 2026 /PRNewswire/ — According to the in-depth study published by MarkNtel Advisors, the Global Artificial Intelligence (AI) in Precision Medicine Market is projected to grow at a CAGR of around 31.35% during 2026-2032. The market expansion is primarily driven by the increasing integration of artificial intelligence in healthcare, rising demand for personalized treatment approaches, growing adoption of genomics and data-driven diagnostics, and the expanding role of AI in enhancing clinical decision-making and drug discovery processes.
http://mma.prnewswire.com/media/2687299/5880316/MarkNtel_Advisors_Logo.jpg
Regionally, North America holds a leading position in the Global Artificial Intelligence (AI) in Precision Medicine Market, accounting for approximately 39% of the overall market share, making it the dominant regional contributor. This leadership is primarily driven by the high prevalence of cancer across the region, including breast, lung, and colorectal cancers, which continue to demand more advanced and personalized therapeutic approaches.
Global Artificial Intelligence (AI) in Precision Medicine Market Key Takeaways
- The Global Artificial Intelligence (AI) in Precision Medicine Market was valued at approximately USD 1.68 billion in 2025 and is projected to grow from USD 2.01 billion in 2026 to around USD 10.32 billion by 2032, reflecting substantial growth driven by the rapid evolution of AI-powered healthcare technologies and increasing investments in precision medicine initiatives globally.
- By therapeutic application, the oncology segment dominated the Global Artificial Intelligence (AI) in Precision Medicine Market with approximately 32.5% share in 2026. This dominance is attributed to the extensive use of AI in cancer diagnosis, biomarker discovery, and personalized treatment planning, supported by the availability of large-scale genomic and clinical datasets.
- By component, the software segment captured nearly 45% of the market share in 2026, driven by the rising demand for AI-based platforms, predictive analytics tools, and clinical decision support systems. Software solutions play a crucial role in processing vast volumes of healthcare data, enabling accurate and efficient medical insights.
- The presence of leading global companies continues to strengthen the competitive landscape through continuous innovation, strategic collaborations, and the development of advanced AI-driven healthcare solutions.
Download a FREE PDF Sample of the Report:
https://www.marknteladvisors.com/query/request-sample/global-artificial-intelligence-in-precision-medicine-market.html
(Explore emerging trends, innovations, and key industry developments.)
Transformative Drivers Fueling the Rapid Adoption of AI in Precision Medicine
- Growing Demand for Personalized Treatment Approaches
The growth of the global AI in precision medicine market is primarily driven by the increasing demand for personalized healthcare solutions tailored to individual patient profiles. Unlike traditional treatment approaches that rely on generalized protocols, precision medicine leverages genetic, environmental, and lifestyle data to deliver highly targeted therapies.
In this context, artificial intelligence plays a pivotal role by analyzing complex and large-scale datasets, identifying hidden patterns, and enabling clinicians to make more accurate, data-driven decisions. Furthermore, the integration of AI with genomics and molecular diagnostics is significantly enhancing treatment precision, particularly in managing complex diseases such as cancer and neurological disorders.
As healthcare systems continue to transition toward patient-centric models, the adoption of AI-driven precision medicine solutions is expected to accelerate, thereby driving substantial market growth.
- Advancements in AI Technologies Enhancing Clinical Outcomes
Building on this momentum, continuous advancements in AI technologies are further strengthening market expansion. Technologies such as machine learning, deep learning, natural language processing (NLP), and context-aware computing are enabling more efficient analysis of electronic health records, medical imaging, and genomic data. As a result, these innovations are facilitating early disease detection and improving treatment planning.
Moreover, AI-powered solutions are increasingly being integrated into drug discovery and development processes, significantly reducing both the time and cost associated with bringing new therapies to market. This growing adoption across the healthcare ecosystem is not only enhancing operational efficiency but also improving overall patient outcomes.
Consequently, the ongoing evolution of AI technologies is expected to play a transformative role in shaping the future of precision medicine.
Key Challenges Limiting Market Growth
- Data Privacy Concerns and High Implementation Costs
Despite the strong growth outlook, the market faces several critical challenges, particularly related to data privacy, security concerns, and high implementation costs. The use of sensitive patient data in AI-driven systems raises significant concerns regarding data protection, regulatory compliance, and ethical considerations.
In addition, integrating AI technologies into existing healthcare infrastructures requires substantial investments in advanced technologies, skilled professionals, and system upgrades, which may hinder adoption, especially in cost-sensitive regions.
However, with ongoing advancements in data security frameworks, increasing regulatory support, and rising investments in digital healthcare infrastructure, these challenges are expected to be gradually mitigated. As a result, the market is likely to witness more streamlined adoption in the coming years.
Market Analysis by Component, Therapeutic Application & Region
By component, the software segment held a dominant position in the Global Artificial Intelligence (AI) in Precision Medicine Market in 2026, accounting for approximately 45% of the total share. This leadership is primarily attributed to the growing reliance on AI-powered platforms for advanced data analytics, predictive modeling, and clinical decision support. Moreover, software solutions enable seamless integration of AI technologies into existing healthcare infrastructures, facilitating improved interoperability and workflow efficiency. As healthcare providers increasingly adopt digital tools to manage complex datasets, the demand for intelligent software continues to rise. Consequently, the software segment remains central to enhancing diagnostic accuracy, optimizing treatment pathways, and driving overall market expansion.
By therapeutic application, oncology emerged as the leading segment in the Global Artificial Intelligence (AI) in Precision Medicine Market, accounting for approximately 32.5% of the total share in 2026. This dominance is largely attributed to the increasing global burden of cancer and the growing need for highly personalized treatment approaches. AI technologies are extensively utilized in cancer care for early detection, tumor classification, biomarker identification, and treatment optimization. Furthermore, the availability of vast genomic and clinical datasets is enabling more accurate and targeted therapies. As a result, the integration of AI in oncology continues to enhance clinical outcomes, reinforcing its strong position in the market.
Regionally, North America holds a leading position in the Global Artificial Intelligence (AI) in Precision Medicine Market, accounting for approximately 39% of the overall market share. This dominance is supported by advanced healthcare infrastructure, strong presence of key industry players, and widespread adoption of digital health technologies. Additionally, the high prevalence of chronic diseases and increased investments in AI-driven healthcare solutions further strengthen regional growth.
View Full Report (All Data, In One Place):
https://www.marknteladvisors.com/research-library/global-artificial-intelligence-in-precision-medicine-market.html
(Explore detailed market analysis, competitive landscape, and growth opportunities)
Strategic Collaborations and AI Innovations Accelerating Precision Medicine Evolution
The Global Artificial Intelligence (AI) in Precision Medicine Market has witnessed a series of transformative developments, reflecting the growing convergence of advanced analytics, genomics, and real-world data integration. In 2024, Zephyr AI strengthened its position in the market by securing USD 111 million in funding, aimed at advancing its AI-driven precision medicine platform. This investment highlights the increasing confidence of stakeholders in AI-powered healthcare solutions and their potential to revolutionize disease understanding and treatment.
Building on this momentum, in 2025, Illumina and Tempus AI announced a strategic collaboration to accelerate the clinical adoption of next-generation sequencing (NGS) technologies. By combining Illumina’s advanced AI capabilities with Tempus’s multimodal data platform, the partnership focuses on developing and training genomic algorithms, thereby enabling faster integration of AI-enhanced genomic insights into clinical practice.
Further reinforcing this trend, Guardant Health and ConcertAI introduced a pioneering multi-modal real-world data (RWD) solution in 2025. This collaboration integrates electronic medical records with genomic and epigenomic tumor profiling across all stages of cancer care, supporting more robust AI-driven oncology research and the development of highly targeted precision therapies.
Collectively, these developments underscore a rapidly evolving landscape where strategic partnerships, data integration, and continuous technological innovation are driving the next phase of growth in AI-enabled precision medicine.
Key Players in the Artificial Intelligence (AI) in Precision Medicine Market
- Tempus
- Intel Corporation
- Zephyr AI
- IBM
- NVIDIA Corporation
- Intuz
- Google LLC
- Persistent Systems
- Owkin, Inc.
- Others
Global Artificial Intelligence (AI) in Precision Medicine Market Scope
By Component: Hardware, Software, ServicesBy Technology: Deep Learning, Machine Learning, Querying Method, Natural Language Processing, Context-Aware ProcessingBy Therapeutic Application: Oncology, Neurosciences, Cardiology, Hematological Diseases, Autoimmune Diseases, OthersBy Region: North America, South America, Europe, Asia-Pacific, Middle East & Africa
Browse More Reports
Global Telemedicine Market
: The Global Telemedicine Market size was valued at USD 79 Billion in 2023 and is projected to reach USD 275 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18% during the forecast period, i.e., 2025-30.
Global Regenerative Medicine Market:
The Global Regenerative Medicine Market size was valued at USD 32 Billion in 2023 and is projected to reach USD 112 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.5% during the forecast period, i.e., 2025-30.
Global Precision Medicine Market
: The Global Precision Medicine Market size was valued at around USD 48.8 Billion in 2023 & is estimated to grow at a CAGR of around 10.6% during the forecast period, i.e., 2024-30.
Global Nanomedicine Therapeutics Market:
The Global Nanomedicine Therapeutics Market is projected to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28.
Global Electroceuticals/Bioelectric Medicine Market
: The Global Electroceuticals/Bioelectric Medicine Market size is estimated to grow at a CAGR of around 7.3% during the forecast period, i.e., 2024-30.
GCC Herbal Medicine Market:
The GCC Herbal Medicine Market size is valued at USD 224.83 Million in 2023 & is estimated to reach USD 366 Million by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.90% during the forecast period, i.e., 2024-30.
Vietnam Telemedicine Market:
The Vietnam Telemedicine Market size was valued at around USD 360 million in 2024 and is projected to reach USD 660 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.52% during the forecast period, i.e., 2025-30.
About MarkNtel Advisors
MarkNtel Advisors is a global market research and consulting firm committed to delivering precise, data-driven insights across a diverse range of high-growth and emerging industries. The firm employs a rigorous research methodology that integrates extensive primary research, featuring direct interactions with industry leaders, subject-matter experts, and key stakeholders, with thoroughly validated secondary data sources. This comprehensive approach ensures the accuracy, reliability, and credibility of its market intelligence.
Backed by deep domain expertise and a team of experienced analysts, MarkNtel Advisors provides strategic insights that enable organizations, investors, and decision-makers to identify emerging opportunities, understand evolving industry dynamics, and make informed business decisions in an increasingly competitive and rapidly evolving global marketplace.
Contact Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, IndiaContact No: +91 87199 99009Email: [email protected]: marknteladvisors.com
Logo – https://mma.prnewswire.com/media/2687299/5880316/MarkNtel_Advisors_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-artificial-intelligence-ai-in-precision-medicine-market-to-attain-usd-10-32-billion-by-2032–witnessing-a-cagr-of-31-35-says-markntel-advisors-302723310.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…